These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22465227)

  • 1. Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.
    Farini A; Sitzia C; Navarro C; D'Antona G; Belicchi M; Parolini D; Del Fraro G; Razini P; Bottinelli R; Meregalli M; Torrente Y
    Exp Cell Res; 2012 Jun; 318(10):1160-74. PubMed ID: 22465227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
    Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
    J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological and immunohistological changes of the skeletal muscles in older SJL/J mice.
    Nemoto H; Konno S; Nakazora H; Miura H; Kurihara T
    Eur Neurol; 2007; 57(1):19-25. PubMed ID: 17108690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
    Gawlik KI; Holmberg J; Durbeej M
    Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sarcolemma in the Large(myd) mouse.
    Reed PW; Mathews KD; Mills KA; Bloch RJ
    Muscle Nerve; 2004 Nov; 30(5):585-95. PubMed ID: 15389724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.
    Han R; Frett EM; Levy JR; Rader EP; Lueck JD; Bansal D; Moore SA; Ng R; Beltrán-Valero de Bernabé D; Faulkner JA; Campbell KP
    J Clin Invest; 2010 Dec; 120(12):4366-74. PubMed ID: 21060153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.
    Chiu YH; Hornsey MA; Klinge L; Jørgensen LH; Laval SH; Charlton R; Barresi R; Straub V; Lochmüller H; Bushby K
    Hum Mol Genet; 2009 Jun; 18(11):1976-89. PubMed ID: 19286669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.
    Frigeri A; Nicchia GP; Balena R; Nico B; Svelto M
    FASEB J; 2004 May; 18(7):905-7. PubMed ID: 15033928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
    Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
    Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.
    Bartoli M; Poupiot J; Goyenvalle A; Perez N; Garcia L; Danos O; Richard I
    Gene Ther; 2006 Jan; 13(1):20-8. PubMed ID: 16107863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.
    Spencer MJ; Walsh CM; Dorshkind KA; Rodriguez EM; Tidball JG
    J Clin Invest; 1997 Jun; 99(11):2745-51. PubMed ID: 9169505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
    Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
    J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.
    Schmidt S; Vieweger A; Obst M; Mueller S; Gross V; Gutberlet M; Steinbrink J; Taubert S; Misselwitz B; Luedemann L; Spuler S
    Radiology; 2009 Jan; 250(1):87-94. PubMed ID: 19001151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of deltaCaMKII isoforms in skeletal muscle regeneration: Implications in dystrophic muscle disease.
    Abraham ST; Shaw C
    J Cell Biochem; 2006 Feb; 97(3):621-32. PubMed ID: 16215994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skinned single fibers from normal and dystrophin-deficient dogs incur comparable stretch-induced force deficits.
    Childers MK; Staley JT; Kornegay JN; McDonald KS
    Muscle Nerve; 2005 Jun; 31(6):768-71. PubMed ID: 15736272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive monitoring of gene correction in dystrophic muscle.
    Walter G; Cordier L; Bloy D; Sweeney HL
    Magn Reson Med; 2005 Dec; 54(6):1369-76. PubMed ID: 16261578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.